Sugi Holdings Co.,Ltd. (TYO: 7649)
Japan
· Delayed Price · Currency is JPY
2,524.50
-4.50 (-0.18%)
Jan 20, 2025, 3:30 PM JST
Sugi Holdings Co.,Ltd. Revenue
Sugi Holdings Co.,Ltd. had revenue of 220.81B JPY in the quarter ending November 30, 2024, with 19.64% growth. This brings the company's revenue in the last twelve months to 827.96B, up 14.55% year-over-year. In the fiscal year ending February 29, 2024, Sugi Holdings Co.,Ltd. had annual revenue of 744.48B with 11.51% growth.
Revenue (ttm)
827.96B
Revenue Growth
+14.55%
P/S Ratio
0.55
Revenue / Employee
94.91M
Employees
8,724
Market Cap
456.85B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Feb 29, 2024 | 744.48B | 76.83B | 11.51% |
Feb 28, 2023 | 667.65B | 42.17B | 6.74% |
Feb 28, 2022 | 625.48B | 22.97B | 3.81% |
Feb 28, 2021 | 602.51B | 60.55B | 11.17% |
Feb 29, 2020 | 541.96B | 53.50B | 10.95% |
Feb 28, 2019 | Pro | Pro | Pro |
Feb 28, 2018 | Pro | Pro | Pro |
Feb 28, 2017 | Pro | Pro | Pro |
Feb 29, 2016 | Pro | Pro | Pro |
Feb 28, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,142.35B |
Daiichi Sankyo Company | 1,758.07B |
HOYA Corporation | 812.74B |
Takeda Pharmaceutical Company | 4,546.08B |
Otsuka Holdings | 2,269.56B |
Terumo | 986.67B |
Astellas Pharma | 1,772.16B |
Olympus | 973.60B |